+ND Capital
Investor profile
Venture capital
+ND Capital has backed 4 European tech companies across 5 funding rounds between 2023 and 2026, joining rounds totalling €177M. Most active in Healthtech and Cleantech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
4
backed
Active span
2023–2026
4 yrs
Total round €
€177M
sum of rounds joined
Deals by year
distinct rounds / year+ND Capital — deals by year — interactive chart.
Data table
| +ND Capital — deals by year | |
|---|---|
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by deals+ND Capital — top sectors — interactive chart.
Data table
| +ND Capital — top sectors | |
|---|---|
| Healthtech | 4 |
| Cleantech | 1 |
| Energy | 1 |
Stages
by deals+ND Capital — stages — interactive chart.
Data table
| +ND Capital — stages | |
|---|---|
| Other | 2 |
| Series A | 1 |
| Series B | 1 |
| Series C | 1 |
Countries
by deals+ND Capital — countries — interactive chart.
Data table
| +ND Capital — countries | |
|---|---|
| Switzerland | 2 |
| UK | 2 |
| Denmark | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- ARCH Venture Partners2
- Illumina Ventures2
- Longwall Ventures2
- M Ventures2
- OMX Ventures2
- 4see Ventures1
- Alexandria Venture Investments1
- Apollo Health Ventures1
- Athos Capital1
- Bernina BioInvest1
- Earlybird Venture Capital1
- Eli lilly and company1
- LifeLink Ventures1
- Longview Ventures1
- Lundbeckfonden BioCapital1
- RTX Ventures1
- Schroders Capital1
- Sofinnova Partners1
- Tippet Venture Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Lightcast Discovery | UK | 2 | €68M |
| haya therapeutics | Switzerland | 1 | €58M |
| H55 | Switzerland | 1 | €47M |
| Notify Therapeutics | Denmark | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| haya therapeutics | Series A | €58M | 2025-05 |
| H55 | Series C | €47M | 2023-09 |
| Lightcast Discovery | Series B | €45M | 2023-08 |
| Lightcast Discovery | Other | €23M | 2026-04 |
| Notify Therapeutics | Other | €5.0M | 2023-09 |